Roundhill GLP-1 & Weight Loss ETF
OZEM
#2851
ETF Rang
€44.82 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
27,00 €
Aktienkurs
0.86%
Veränderung (1 Tag)
35.65%
Veränderung (1 Jahr)

Roundhill GLP-1 & Weight Loss ETF - Bestände

ETF-Bestände zum Stand 10. April 2026Anzahl der Bestände: 29

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
16.30%
Eli Lilly & CoLLY9003
13.04%
Novo Nordisk A/SNVO183834
7.14%
Pfizer IncPFE138419
5.53%
Viking Therapeutics IncVKTX83569
5.15%
Innovent Biologics Inc1801 HK242500
4.87%
Ascletis Pharma Inc1672 HK1133000
3.91%
Roche Holding AGROP SW5146
3.88%
Amgen IncAMGN5762
3.81%
AstraZeneca PLCAZN9819
3.58%
Zealand Pharma A/SZEAL DC40685
3.48%
Hanmi Pharm Co Ltd128940 KS5593
3.43%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.23%
Regeneron Pharmaceuticals IncREGN2218
3.21%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
2.86%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.65%
Structure Therapeutics IncGPCR25378
2.34%
United Laboratories International Holdings Ltd/The3933 HK954000
2.28%
Gubra A/SGUBRA DC22723
2.13%
MBX Biosciences IncMBX34264
1.90%
Gilead Sciences IncGILD7043
1.38%
Rhythm Pharmaceuticals IncRYTM8463
1.35%
Shionogi & Co Ltd4507 JP32700
1.00%
First American Government Obligations Fund 12/01/2031FGXXX526856.59
0.94%
Biohaven LtdBHVN53094
0.44%
WaVe Life Sciences LtdWVE32778
0.43%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.19%
Cash & OtherCash&Other100860.82
0.05%
JAPANESE YENJPY4195210
-0.52%
SWISS FRANCCHF-215321.29